Table 2.
No causal relation with BPO | Possible causal relation with BPO | |||||
---|---|---|---|---|---|---|
2.5% BPO gel | 5% BPO gel | 2.5% + 5% | 2.5% BPO gel | 5% BPO gel | 2.5% + 5% | |
No. of cases (%) | No. of cases (%) | No. of cases (%) | No. of cases (%) | No. of cases (%) | No. of cases (%) | |
No. of subjects analyzed | 231 | 227 | 458 | 231 | 227 | 458 |
No. of adverse events | 194 (84.0) | 198 (87.2) | 392 (85.6) | 114 (49.4) | 125 (55.1) | 239 (52.2) |
Mild | 191 (82.7) | 195 (85.9) | 386 (84.3) | 111 (48.1) | 123 (54.2) | 234 (51.1) |
Moderate | 17 (7.4) | 14 (6.2) | 31 (6.8) | 5 (2.2) | 5 (2.2) | 10 (2.2) |
Severe | 1 (0.4) | 1 (0.4) | 2 (0.4) | 0 | 0 | 0 |
Very severe | 3 (1.3) | 2 (0.9) | 5 (1.1) | 0 | 0 | 0 |
Noteworthy reactions | 7 (3.0) | 12 (5.3) | 19 (4.1) | 6 (2.6) | 11 (4.8) | 17 (3.7) |
BPO, benzoyl peroxide.